Nutri Pharma acquires Bionor Immuno - MarketLine Financial Deals

Nutri Pharma acquires Bionor Immuno

Nutri Pharma acquires Bionor Immuno - MarketLine Financial Deals
Nutri Pharma acquires Bionor Immuno
Published Feb 12, 2010
2 pages — Published Feb 12, 2010
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Nutri Pharma ASA, a developer of soy technology for treatment and prevention of life-style related diseases, has acquired a 98.3% stake in Bionor Immuno AS, a biotechnology company

  
Source:
Document ID
MA17673_100125
Country
Ticker
NUT=NO
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Nutri Pharma acquires Bionor Immuno" Feb 12, 2010. Alacra Store. Dec 09, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Nutri-Pharma-acquires-Bionor-Immuno-2052-22380>
  
APA:
MarketLine Financial Deals. (2010). Nutri Pharma acquires Bionor Immuno Feb 12, 2010. New York, NY: Alacra Store. Retrieved Dec 09, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Nutri-Pharma-acquires-Bionor-Immuno-2052-22380>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.